Ramucirumab Plus FOLFOX as Front-Line Treatment in Advanced Gastric Cancer - 100285

Spotlight
Video

Ramucirumab Plus FOLFOX as Front-Line Treatment in Advanced Gastric Cancer

feeds has 409 videos Subscribe Here

Loading........
Description: Dr. Bendell discusses the results of a randomized, double-blind, multicenter phase 2 trial that examined FOLFOX plus or minus ramucirumab as front-line therapy for advanced gastric or esophageal adenocarcinoma.
Dr. Bendell, MD, Director of GI Cancer Research Program, associate director, Drug Development Program, Sarah Cannon Research Institute,
Shared By : feeds
Posted on : 05/13/15
Added : 3 years ago